Titan Pharmaceuticals Inc
TTNPDelisted Oct 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000910267
Titan Pharmaceuticals Inc was delisted on Oct 2, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 18 institutions reported holding it in 13F filings for Q3 2025, worth $107.1K in total; no superinvestor held it.
Q3 2025 vs. Q2 2025
How the institutions holding Titan Pharmaceuticals Inc changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 20 | 18 | −2 |
| Shares | 37.7K | 22.4K | −15.3K (−40.7%) |
| Value | $158.3K | $107.1K | −$51.2K (−32.3%) |
New holders (3)
Institutions that held Titan Pharmaceuticals Inc at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DRW Securities, LLC | 21,267 | $101.9K | 0.01% |
| Tower Research Capital LLC (TRC) | 469 | $2.25K | 0.00% |
| CWM, LLC | 1 | $0 | 0.00% |
Sold out (5)
Institutions that held Titan Pharmaceuticals Inc at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Citadel Advisors LLC | 12,069 | $50.7K |
| Renaissance Technologies LLC | 11,380 | $47.8K |
| Marex Group plc | 10,663 | $44.8K |
| Raymond James Financial Inc | 1 | $4 |
| Cape Investment Advisory, Inc. | 1 | $4 |